DR. RECKEWEG R35 ChadontinCombination Product (PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO)


Welcome to the PulseAid listing for the DR. RECKEWEG R35 Chadontin drug offered from PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
NON-PROPRIETARY NAME: Aconitum napellus 6X, Bryonia 30X, Calcarea carbonica 30X, Chamomilla 4X, Colocynthis 12X, Ignatia amara 30X, Staphysagria 8X
SUBSTANCE NAME: ACONITUM NAPELLUS; BRYONIA DIOICA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; MATRICARIA RECUTITA; CITRULLUS COLOCYNTHIS FRUIT PULP; STRYCHNOS IGNATII SEED; DELPHINIUM STAPHISAGRIA SEED
TYPE: HUMAN OTC DRUG
PHARMA CLASS:
ROUTE: ORAL
DOSAGE FORM: LIQUID
MARKETING CATEGORY NAME: UNAPPROVED HOMEOPATHIC
START MARKETING DATE: 1986-06-01
END MARKETING DATE: 0000-00-00


DR. RECKEWEG R35 Chadontin Combination Product HUMAN OTC DRUG Details:

Item DescriptionDR. RECKEWEG R35 Chadontin Combination Product from PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
LABELER NAME: PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CO
DEA SCHEDULE:
ACTIVE STRENGTH: 6; 30; 30; 4; 12; 30; 8([hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL; [hp_X]/50mL)
START MARKETING DATE: 1986-06-01
END MARKETING DATE: 0000-00-00
PRODUCT ID: 53346-1335_af0d4920-b8b7-49f1-a16d-18a77032ea1b
PRODUCT NDC: 53346-1335
APPLICATION NUMBER:

Other ACONITUM NAPELLUS; BRYONIA DIOICA ROOT; OYSTER SHELL CALCIUM CARBONATE, CRUDE; MATRICARIA RECUTITA; CITRULLUS COLOCYNTHIS FRUIT PULP; STRYCHNOS IGNATII SEED; DELPHINIUM STAPHISAGRIA SEED Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
PHARMAZEUTISCHE FABRIK DR. RECKEWEG & CODR. RECKEWEG R35 Chadontin